Skip to main content
TipRanks
Go Ultimate75% OFF

Top Page

ITWO

ProShares Russell 2000 High Income ETF (ITWO)

Rating:58Neutral
Price Target:$44.00â–²(12.07% Upside)

ITWO, the ProShares Russell 2000 High Income ETF, has a solid overall rating driven mainly by strong, diversified holdings like CareTrust REIT, UMB Financial, Moog, JFrog, and Jackson Financial, which show healthy revenue growth, strategic expansion, and supportive technical trends. However, several holdings such as Glaukos, BrightSpring Health Services, ViaSat, and TG Therapeutics face profitability, leverage, or momentum challenges that limit the fund’s upside. The main risk factor is exposure to multiple companies with high leverage, overbought technical signals, or weak current profitability, which can increase volatility even as the fund benefits from generally positive growth and earnings trends.

Positive Factors
Strong Top HoldingsSeveral of the largest positions, especially in health care and technology, have shown strong gains this year, helping support the ETF’s overall results.
Broad Sector DiversificationThe fund spreads its assets across many sectors, including health care, financials, technology, and industrials, which helps reduce the impact if any one industry struggles.
Positive Year-To-Date PerformanceDespite recent short-term weakness, the ETF’s performance so far this year has been positive, suggesting it has held up reasonably well over a longer recent period.
Negative Factors
Recent Short-Term WeaknessThe ETF has shown weak performance over the past one and three months, which may signal near-term volatility or pressure on its holdings.
High U.S. ConcentrationWith the vast majority of its assets in U.S. companies, the fund offers limited geographic diversification and is heavily tied to the U.S. market.
Moderate Expense RatioThe fund’s expense ratio is not especially low, meaning a noticeable portion of returns will go toward fees compared with some cheaper ETFs.

ITWO vs. SPDR S&P 500 ETF (SPY)

-5%0%5%10%15%20%25%30%SPY+4.27%ITWO+7.13%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AUM
172.66M
Region
North America
Expense Ratio
0.55%
Beta
0.91
Issuer
ProShares
Inception Date
Sep 04, 2024
Dividend Yield
8.51%
Asset Class
Equity
Index Tracked
Cboe Russell 2000 Daily Covered Call Index - Benchmark TR Gross

ITWO Summary

The ProShares Russell 2000 High Income ETF (ITWO) invests in smaller U.S. companies and follows the Russell 2000 High Dividend Index, focusing on small-cap stocks that pay relatively high dividends. It holds a wide mix of businesses across health care, financials, technology, and more, including names like JFrog and SM Energy. Someone might consider this ETF to seek both income from dividends and potential growth from smaller, fast-moving companies, while getting diversification across many stocks. A key risk is that small-cap stocks can be more volatile, so the ETF’s price can move up and down more sharply than the overall market.

How much will it cost me?

This ETF has an expense ratio of 0.55%, which means you’ll pay about $5.50 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because this fund uses a more specialized, income-focused strategy rather than plain passive market tracking.

What would affect this ETF?

This ETF focuses on U.S. small-cap companies with high dividend income, so it could benefit if the U.S. economy grows steadily, interest rates eventually ease, and sectors like health care, financials, technology, and energy perform well. On the downside, small caps can be hit harder by economic slowdowns, higher-for-longer interest rates, tighter credit conditions, or sector-specific issues in areas like health care and financials, which could hurt both stock prices and dividend payouts.

ITWO Top 10 Holdings

ITWO is powered by a quirky mix of small-cap health care, tech, and energy names, all U.S.-based. Glaukos and 10x Genomics have been rising stars, giving the fund a lift as investors warm to innovative medical and life-science plays. SM Energy and Brinker International add some steady, cash-generating muscle, helping balance out the more volatile growth names. On the softer side, Twist Bioscience has been mixed and losing steam lately, while Moog and UMB Financial have been more subdued, keeping overall performance in check rather than turbocharged.

ITWO top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
GKOSGKOSGlaukos0.46%$772.40K$14.09B149.28%61Neutral
FROGFROGJFrog0.40%$670.92K$13.62B70.41%73Outperform
HZNHZNBright Horizon Energy0.36%$611.60K$48.81M12.20%74Outperform
BTSGBTSGBrightSpring Health Services, Inc.0.36%$605.25K$12.74B91.82%67Neutral
UMBFUMBFUMB Financial0.32%$535.41K$9.79B21.20%77Outperform
TGTXTGTXTG Therapeutics0.31%$531.30K$9.81B108.01%65Neutral
MOG.AMOG.AMoog0.31%$527.86K$10.39B68.44%73Outperform
RHPRHPRyman0.30%$509.61K$9.21B47.10%66Neutral
CTRECTRECareTrust REIT0.30%$500.99K$9.54B1.49%80Outperform
JXNJXNJackson Financial Incorporation0.29%$482.22K$8.56B38.44%73Outperform

ITWO Technical Analysis

Technical Analysis SentimentNegative
Last Price39.26

Price Trends

50DMA42.69Negative
100DMA43.93Negative
200DMA42.52Negative

Market Momentum

MACD-0.61Positive
RSI29.52Positive
STOCH6.71Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ITWO, the sentiment is Negative. The current price of 39.26 is below the 20-day moving average (MA) of 42.45, below the 50-day MA of 42.69, and below the 200-day MA of 42.52, indicating a bearish trend. The MACD of -0.61 indicates Positive momentum. The RSI at 29.52 is Positive, neither overbought nor oversold. The STOCH value of 6.71 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ITWO.

ITWO Peer Comparison

Comparison Results

ITWO against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
ITWOITWO$39.26$44.00(12.07% Upside)$172.66M0.55%58Neutral
SFLOSFLO$36.27$47.49(30.95% Upside)$902.31M0.49%68Neutral
OUSMOUSM$47.02$53.77(14.35% Upside)$810.00M0.48%72Outperform
BBSCBBSC$79.33$106.57(34.33% Upside)$705.70M0.09%63Neutral
JHSCJHSC$44.73$55.86(24.86% Upside)$675.58M0.42%67Neutral
EESEES$61.53$80.70(31.15% Upside)$652.44M0.38%68Neutral

Performance Comparison

0%10%20%30%40%ITWOSFLOOUSMBBSCJHSCEESDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
ITWO and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
ITWOProShares Russell 2000 High Income ETF39.263.349.31%
SFLOVictoryShares Small Cap Free Cash Flow ETF36.278.1228.86%
OUSMOShares U.S. Small-Cap Quality Dividend ETF47.024.9511.76%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity ETF79.337.3310.18%
JHSCJohn Hancock Multifactor Small Cap ETF44.734.019.85%
EESWisdomTree U.S. SmallCap Fund61.537.5013.87%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.